検索結果

. Launch and Distribution of “MIEr for BeelineMED” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution of “MIEr for BeelineMED” in Japan. MIEr for BeelineMED is cap...

.：J. Ocul. Pharmacol. 1993; 9(4): 373-384. (PMID: 7906296) 3) Tissié, G. et al.：J. Ocul. Pharmacol. Ther. 2002; 18(1): 65-73. (PMID: 11858616) 4) 山本 哲也ほか：日本眼科学会雑誌. 2007; 111(6): 463-472. 5) 川瀬 和秀ほか：日本...

CEO Message | About Senju | SENJU Pharmaceutical

been making efforts for more than 70 years to develop excellent medicines and services focusing on the ophthalmology field through our unique ideas and R&D capabilities.Throughout our history, we...

Business Activities | About Senju | SENJU Pharmaceutical

Based on a sense of mission to contribute to the health of the eyes of people around the world, and a development policy that puts top priority on safety, we have always taken a pioneering path in oph...

Management Policy | About Senju | SENJU Pharmaceutical

valuable for society, we are committed to pursuing happiness for all people associated with Senju rather than just becoming a “big company” that pursues only greater growth and increased sales. Action...